e.l.f. Beauty, Inc. ELF
Composite 40/100; the shares have moved about 58% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 17/100 — a strong mark against it.
Balance-sheet strength ranks 58/100 — a slight point in its favour. Momentum ranks 52/100 — a slight point in its favour.
Valuation ranks 17/100 — a strong mark against it. Quality ranks 32/100 — a moderate mark against it. Growth ranks 45/100 — a slight mark against it.
What the company does e.l.f. Beauty (ELF) designs, manufactures, and sells affordable cosmetics and skin care products globally under brands such as e.l.f. Cosmetics, Naturium, and Rhode. It distributes via mass retailers, specialty stores, and direct-to-consumer e-commerce.
Key financials Revenue grew 35.1% YoY with EPS up 116.7%, yet net margin is -0.2% and ROE -0.3%. Gross margin is 61.0% but operating margin is only 1.7%. Debt/Equity is 0.81 and interest coverage is 1.99.
Stock health Sideravia scores ELF 39.3/100 (“poor quality, richly valued”) with Quality 24.5 and Valuation 19.4. Piotroski F-Score is 4/9 and Altman Z is 3.10. RSI(14) is 63.10.
Price vs fair value ELF trades at a PREMIUM of 19.40% to our fair-value estimate of 66.29 and a PREMIUM of 4.19% to the 12-month target of 78.81. - Analysts highlight margin pressure raising valuation questions (Simply Wall St.) - Demand scrutiny persists despite expected strong quarterly results (Proactive) - Stock up 5.3% after margin squeeze tests profitability of growth story (Simply Wall St.) - ELF remains stretched on premium sales expectations (Simply Wall St.)
Looking forward Forward P/E is 23.42 vs trailing 175.82, implying earnings must expand sharply. PEG of 0.04 suggests extreme growth expectations. Analysts expect ELF to beat earnings estimates, but margin recovery is key to justify current multiples.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.